Alex Zhenghong Fu, Ph.D.
Quantitative Health Sciences /JJN3

Telephone: (216) 445-7745
Fax: (216) 445-2781
fuz@ccf.org

Positions:

Assistant Staff, Health Outcome Research and Clinical Epidemiology,
Department of Quantitative Health Sciences,
Cleveland Clinic, 2005-present

Assistant Professor of Medicine,
Cleveland Clinic Lerner College of Medicine,
Case Western Reserve University, 2006-present

Education:

B.S., Genetics and Cell Biology, Beijing University, China.
M.S., Pharmaceutical Policy and Evaluative Sciences, University of North Carolina at Chapel Hill, 2002.
Ph.D., Pharmaceutical Policy and Evaluative Sciences, University of North Carolina at Chapel Hill, 2005.

Key Interests:

Dr. Fu’s current research interests include health economics, pharmacoeconomics, health outcome and health service research, health policy and economic evaluations. He is currently working on several clinical trials with a focus on cost-effectiveness data collection, decision-tree modeling, and cost-effectiveness analysis. Dr. Fu also has special research interests in utility assessment, propensity score method, econometrics, and mental health illnesses.

Selected Publications:

Fu AZ, Dow WH, Liu GG. Propensity score and difference-in-difference methods: a study of second-generation antidepressant use in patients with bipolar disorder. Health Services and Outcomes Research Methodology 2007 Jun;7(1-2): 23-38.

Fu AZ, Liu GG, Christensen DB, Hansen RA. Effect of second-generation antidepressants on mania- and depression-related visits in adults with bipolar disorder: a retrospective study. Value in Health 2007 Mar-Apr;10(2):128-36.

Golshayan AR, Jin T, Maciejewski J, Fu AZ, Bershadsky B, Kattan MW, Kalaycio ME, Sekeres MA. Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes. British Journal of Haematology 2007 Apr;137(2): 125-132.

Sekeres MA, Fu AZ, Maciejewski JP, Golshayan AR, Kalaycio ME, Kattan MW. A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes. Cancer 2007 Mar 15;109(6):1125-32.

Fu AZ, Kattan MW. Racial and ethnic differences in preference-based health status measure. Current Medical Research and Opinion 2006 Dec;22(12): 2439-2448.

Fu AZ, Christensen DB, Hansen RA, Liu GG. Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysis. Clinical Therapeutics 2006 Jun;28(6): 979–989.

Calvert N, Burch SP, Fu AZ, Reeves P, Thompson TR. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder. Journal of Managed Care Pharmacy 2006 May;12(4): 322-330.

Tepper SJ, Martin V, Burch SP, Fu AZ, Kwong WJ, Downs KE. Acute headache treatments in patients with health care coverage: what prescriptions are doctors writing? Headache and Pain: Diagnostic Challenges, Current Therapy 2006 Jan;17(1): 11-17.

Fu AZ, Krishnan AA, Harris SD, Tompson TR. The economic burden of bipolar-related phases of depression versus mania. Drug Benefit Trends 2004 Nov;16(11): 569-575.

Fu AZ, Liu GG, Christensen DB. Inappropriate medication use and health outcomes in the elderly. Journal of the American Geriatrics Society 2004 Nov;52(11):1934-1939.

Liu GG, Dow WH, Fu AZ, Akin J. Health human capital and income growth in China. China Economic Quarterly 2004 Jan;4(1): 101-116.

Liu GG, Wu X, Peng C, Fu AZ. Urbanization and access to health care in China. Contemporary Economic Policy 2003 Jan;21(1):11-24.

Guo JD, Liu GG, Christensen DB, Fu AZ. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance. Value in Health 2003 Jan-Feb;6(1):18-28.


This page was last revised in April 2007, and has been accessed 1415 times.